BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28611597)

  • 1. Functional Properties of Human NMDA Receptors Associated with Epilepsy-Related Mutations of GluN2A Subunit.
    Sibarov DA; Bruneau N; Antonov SM; Szepetowski P; Burnashev N; Giniatullin R
    Front Cell Neurosci; 2017; 11():155. PubMed ID: 28611597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional Investigation of a GRIN2A Variant Associated with Rolandic Epilepsy.
    Xu XX; Liu XR; Fan CY; Lai JX; Shi YW; Yang W; Su T; Xu JY; Luo JH; Liao WP
    Neurosci Bull; 2018 Apr; 34(2):237-246. PubMed ID: 28936771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A de novo loss-of-function GRIN2A mutation associated with childhood focal epilepsy and acquired epileptic aphasia.
    Gao K; Tankovic A; Zhang Y; Kusumoto H; Zhang J; Chen W; XiangWei W; Shaulsky GH; Hu C; Traynelis SF; Yuan H; Jiang Y
    PLoS One; 2017; 12(2):e0170818. PubMed ID: 28182669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opportunities for Precision Treatment of
    Han W; Yuan H; Allen JP; Kim S; Shaulsky GH; Perszyk RE; Traynelis SF; Myers SJ
    J Pharmacol Exp Ther; 2022 Apr; 381(1):54-66. PubMed ID: 35110392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GRIN2A-related disorders: genotype and functional consequence predict phenotype.
    Strehlow V; Heyne HO; Vlaskamp DRM; Marwick KFM; Rudolf G; de Bellescize J; Biskup S; Brilstra EH; Brouwer OF; Callenbach PMC; Hentschel J; Hirsch E; Kind PC; Mignot C; Platzer K; Rump P; Skehel PA; Wyllie DJA; Hardingham GE; van Ravenswaaij-Arts CMA; Lesca G; Lemke JR;
    Brain; 2019 Jan; 142(1):80-92. PubMed ID: 30544257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional assessment of triheteromeric NMDA receptors containing a human variant associated with epilepsy.
    Marwick KFM; Hansen KB; Skehel PA; Hardingham GE; Wyllie DJA
    J Physiol; 2019 Mar; 597(6):1691-1704. PubMed ID: 30604514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a GRIN2A de novo mutation associated with epilepsy and intellectual disability on NMDA receptor currents and Mg(2+) block in cultured primary cortical neurons.
    Marwick K; Skehel P; Hardingham G; Wyllie D
    Lancet; 2015 Feb; 385 Suppl 1():S65. PubMed ID: 26312887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired vocal communication, sleep-related discharges, and transient alteration of slow-wave sleep in developing mice lacking the GluN2A subunit of N-methyl-d-aspartate receptors.
    Salmi M; Del Gallo F; Minlebaev M; Zakharov A; Pauly V; Perron P; Pons-Bennaceur A; Corby-Pellegrino S; Aniksztejn L; Lenck-Santini PP; Epsztein J; Khazipov R; Burnashev N; Bertini G; Szepetowski P
    Epilepsia; 2019 Jul; 60(7):1424-1437. PubMed ID: 31158310
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Liu XR; Xu XX; Lin SM; Fan CY; Ye TT; Tang B; Shi YW; Su T; Li BM; Yi YH; Luo JH; Liao WP
    Front Mol Neurosci; 2021; 14():720984. PubMed ID: 34720871
    [No Abstract]   [Full Text] [Related]  

  • 10. Efavirenz restored NMDA receptor dysfunction and inhibited epileptic seizures in
    Zhao T; Zhong R; Zhang X; Li G; Zhou C; Fang S; Ding Y; Lin W
    Front Neurosci; 2023; 17():1086462. PubMed ID: 36937661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic Insight into NMDA Receptor Dysregulation by Rare Variants in the GluN2A and GluN2B Agonist Binding Domains.
    Swanger SA; Chen W; Wells G; Burger PB; Tankovic A; Bhattacharya S; Strong KL; Hu C; Kusumoto H; Zhang J; Adams DR; Millichap JJ; Petrovski S; Traynelis SF; Yuan H
    Am J Hum Genet; 2016 Dec; 99(6):1261-1280. PubMed ID: 27839871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Rare Variant Identified Within the GluN2B C-Terminus in a Patient with Autism Affects NMDA Receptor Surface Expression and Spine Density.
    Liu S; Zhou L; Yuan H; Vieira M; Sanz-Clemente A; Badger JD; Lu W; Traynelis SF; Roche KW
    J Neurosci; 2017 Apr; 37(15):4093-4102. PubMed ID: 28283559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential functional consequences of GRIN2A mutations associated with schizophrenia and neurodevelopmental disorders.
    Shepard N; Baez-Nieto D; Iqbal S; Kurganov E; Budnik N; Campbell AJ; Pan JQ; Sheng M; Farsi Z
    Sci Rep; 2024 Feb; 14(1):2798. PubMed ID: 38307912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Epilepsy-Associated GRIN2A Rare Variant Disrupts CaMKIIα Phosphorylation of GluN2A and NMDA Receptor Trafficking.
    Mota Vieira M; Nguyen TA; Wu K; Badger JD; Collins BM; Anggono V; Lu W; Roche KW
    Cell Rep; 2020 Sep; 32(9):108104. PubMed ID: 32877683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Frameshift Variant of GluN2A Identified in an Epilepsy Patient Results in NMDA Receptor Mistargeting.
    Vieira MM; Peng S; Won S; Hong E; Inati SK; Thurm A; Thiam AH; Kim S; Myers SJ; Badger JD; Traynelis SF; Lu W; Roche KW
    J Neurosci; 2024 Jan; 44(4):. PubMed ID: 38050135
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical Forms and
    Li X; Xie LL; Han W; Hong SQ; Ma JN; Wang J; Jiang L
    Front Pediatr; 2020; 8():574803. PubMed ID: 33240831
    [No Abstract]   [Full Text] [Related]  

  • 17.
    Gheța I; Teleanu RI; Roza E; Carapancea E; Vladacenco O; Teleanu DM
    Neurol Int; 2021 Apr; 13(2):184-189. PubMed ID: 33946630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo GRIN2A variants associated with epilepsy and autism and literature review.
    Mangano GD; Riva A; Fontana A; Salpietro V; Mangano GR; Nobile G; Orsini A; Iacomino M; Battini R; Astrea G; Striano P; Nardello R
    Epilepsy Behav; 2022 Apr; 129():108604. PubMed ID: 35217385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imprecision in Precision Medicine: Differential Response of a Disease-Linked GluN2A Mutant to NMDA Channel Blockers.
    Gale JR; Kosobucki GJ; Hartnett-Scott KA; Aizenman E
    Front Pharmacol; 2021; 12():773455. PubMed ID: 34776984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence That GRIN2A Mutations in Melanoma Correlate with Decreased Survival.
    D'mello SA; Flanagan JU; Green TN; Leung EY; Askarian-Amiri ME; Joseph WR; McCrystal MR; Isaacs RJ; Shaw JH; Furneaux CE; During MJ; Finlay GJ; Baguley BC; Kalev-Zylinska ML
    Front Oncol; 2014 Jan; 3():333. PubMed ID: 24455489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.